← Back to Search

Patient Portal Intervention for Type 2 Diabetes

N/A

Recruiting

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with T2D >6 months

Able to read in English or Spanish

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months

Awards & highlights

Study Summary

This trial will develop and test a multi-level intervention to get patients with diabetes to use electronic portals to manage their health.

Who is the study for?

This trial is for adults over 18 with Type 2 Diabetes (T2D) who have been patients at partner community health centers, can read English or Spanish, and are not currently using the patient portal. They must have had T2D for more than six months and an A1c level above 7.5%. People with gestational diabetes or cognitive impairment that affects their ability to participate in the study cannot join.Check my eligibility

What is being tested?

The study is testing a program designed to help people with Type 2 Diabetes use a patient portal more effectively as part of managing their condition. The intervention includes various strategies implemented at different levels within community health centers.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medications, traditional side effects are not expected. However, participants may experience challenges such as frustration or confusion when learning new technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with type 2 diabetes for more than 6 months.

Select...

I can read in English or Spanish.

Select...

I am older than 18 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in A1C value

Usage of Portal

Secondary outcome measures

Diabetes Self-Efficacy

Health Care Climate Questionnaire

Health care engagement - negative

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Use of patient portal for diabetes managementExperimental Treatment1 Intervention

A multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,509 Total Patients Enrolled

Yale UniversityLead Sponsor

1,848 Previous Clinical Trials

2,737,788 Total Patients Enrolled

National Institute on Minority Health and Health Disparities (NIMHD)NIH

382 Previous Clinical Trials

1,216,131 Total Patients Enrolled

Media Library

Use of patient portal for diabetes management Clinical Trial Eligibility Overview. Trial Name: NCT05180721 — N/A

Type 2 Diabetes Research Study Groups: Use of patient portal for diabetes management

Type 2 Diabetes Clinical Trial 2023: Use of patient portal for diabetes management Highlights & Side Effects. Trial Name: NCT05180721 — N/A

Use of patient portal for diabetes management 2023 Treatment Timeline for Medical Study. Trial Name: NCT05180721 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently recruiting participants?

"Affirmative - according to the clinicaltrials.gov website, this trial is actively seeking participants for enrollment. The initial posting was October 3rd 2022 and there has been recent activity in November 2nd of that same year. They are looking for 36 patients across two medical facilities."

Answered by AI

What is the primary intent of this clinical research?

"The primary purpose of this clinical trial, measured on a Baseline, 3-month and 6-month timeline, is to gauge Portal usage. Secondary objectives include evaluation of Healthcare engagement (positively reflected through medication refills and clinic appointments) as well as ER visits or hospitalizations over the previous 3 months. Finally biometric data such as test results and blood glucose uploads are logged in order to track patient health status."

Answered by AI

To what extent is the enrollment for this experiment open?

"Affirmative. Clinicaltrials.gov reveals that this investigation is presently enrolling volunteers from two distinct sites, since its inception on October 3rd 2022 and last revision on November 2nd of the same year. Approximately 36 participants need to be enrolled for proper data collection."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Multi-level Intervention to Increase Access and Use of the Patient Portal

2022. "A Multi-level Intervention to Increase Access and Use of the Patient Portal". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05180721.

All > Diabetes Type 2